Hypothyroidism and weight loss injections: what you need to decide

What GLP-1 medicines do (and what they don't do) for thyroid-related weight gain

A lot of people with hypothyroidism reach out to us after years of being told their weight is simply a thyroid problem and not much can be done beyond levothyroxine. That frustration is real and it's worth being honest about what weight loss injections can and cannot offer here.

Tirzepatide (Mounjaro) and semaglutide (Wegovy) work by mimicking gut hormones that regulate appetite and slow the rate at which your stomach empties. They reduce how hungry you feel and increase how full you feel after eating. What they do not do is correct thyroid hormone levels or reverse the metabolic effects of an underactive thyroid. That means if your hypothyroidism is poorly controlled, a weight loss injection is unlikely to compensate — getting your thyroid levels stable first is generally the clinical priority.

Where the evidence is more encouraging is for people whose hypothyroidism is already well-managed on levothyroxine. In that situation, weight-related conditions such as raised blood pressure, high cholesterol or pre-diabetes (all of which can accompany hypothyroidism) may bring you within the licensed eligibility criteria for these medicines (BMI 27 or above with at least one weight-related condition, or BMI 30 and above regardless). The prescriber still assesses every case individually. The NHS medicines page for tirzepatide sets out the full eligibility and contraindication picture in plain language.

The thyroid cancer precaution, who it affects and what it means in practice

This is the uncertainty that carries the highest safety weight, so it deserves a clear, unexaggerated explanation. Both Mounjaro and Wegovy carry a contraindication for people with a personal or family history of medullary thyroid carcinoma (MTC), or for those with Multiple Endocrine Neoplasia syndrome type 2 (MEN2). This stems from signals seen in animal studies; a direct causal link in humans has not been established, but the precaution exists precisely because the risk cannot be ruled out.

For most people with hypothyroidism (including those with autoimmune Hashimoto's thyroiditis, by far the most common cause of an underactive thyroid in the UK) this precaution does not apply. Hashimoto's is not a thyroid cancer and is not associated with MTC or MEN2. If, however, your thyroid condition arose from surgery or radioiodine treatment for a previous thyroid tumour, or if anyone in your close family has had MTC, you should raise this explicitly during your consultation. Our page on weight loss injections and thyroid cancer covers this precaution in more detail if you want to read further before speaking to a prescriber.

A straightforward one-minute check: look at any thyroid letters or blood test results you have at home and note whether MTC, MEN2, or follicular versus papillary thyroid cancer appears anywhere. That small piece of admin could save important clinical time during your consultation.

Levothyroxine absorption and the practical conversation to have with your GP

Because GLP-1 medicines slow gastric emptying, there is a plausible mechanism by which the absorption of other oral medicines (including levothyroxine) could be affected. This is not a reason to avoid the combination, but it is a reason for your thyroid-stimulating hormone (TSH) levels to be monitored more closely in the months after starting treatment. Most endocrinologists and GPs who manage hypothyroidism are now familiar with this consideration, given how widely these injections are used.

The practical step is simple: tell your GP you are starting or considering a GLP-1 medicine, so they can schedule a TSH check a few months in. You can also explore how weight loss injections are approached for thyroid patients as a broader read. The NHS England clinical framework for weight management injections explicitly recommends keeping your GP informed and involved when you start treatment, and our prescribers notify your GP as a matter of course in line with GPhC guidance.

Who decides whether this is right for you, and how the consultation works

The decision sits with a prescriber who can see your full clinical picture. Our team reviews every consultation personally, a GPhC-registered Independent Prescriber reads your answers and your health history the same day, not a software system making an automated pass/fail. If hypothyroidism is part of your background, they will consider whether your levels are stable, whether any contraindications apply, whether your current medicines need to be flagged to your GP, and whether the licensed eligibility criteria are met.

If you have ever wondered about the difference between the two main injections in this context, our overview of weight loss injections and thyroid issues compares the available options side by side. For a broader look at the full range of treatments we offer, the treatment options page is the clearest starting point. Our dedicated page on underactive thyroid and these injections also answers some of the more specific questions that come up once people are ready to start. And if you want to understand the wider clinical team making those decisions, our clinical lead's profile is there to read.

These are prescription medicines. A prescriber decides.